Alentis Therapeutics raised €11M in a Series A round in Apr 2019. The company is based in Basel, Switzerland. Investors in the round: BioMedPartners, Pureos Bioventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
